Neurothrombectomy Devices Market Players:
- Penumbra Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- AngioDynamics, Inc.
- Edwards Lifesciences Corporation
- Medtronic
- Stryker Corporation
- Vesalio
- ACANDIS GmbH
- Boston Scientific Corporation
- Abbott Laboratories
- phenox GmbH
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of neurothrombectomy devices is estimated at USD 940.91 million.
The global neurothrombectomy devices market size crossed USD 874.05 million in 2025 and is likely to register a CAGR of around 8.5%, exceeding USD 1.98 billion revenue by 2035.
North America neurothrombectomy devices market is predicted to capture 36% share by 2035, driven by the increasing occurrence of ischemic strokes in the region.
Key players in the market include Penumbra Inc., AngioDynamics, Inc., Edwards Lifesciences Corporation, Medtronic, Stryker Corporation, Vesalio, ACANDIS GmbH, Boston Scientific Corporation, Abbott Laboratories, phenox GmbH.
